Human patients are given fenbendazole as a therapy for cancer
Fenbendazole, an anthelmintic medication, has been used to treat worm infestations since the 1970s.
Despite this, fenbendazole has been found to be effective in the treatment of a broad range of human tumors in a number of recent research and publications that have been sent to peer review. Here are a few factors that may explain why fenbendazole is effective against cancer, as shown by research.
Several investigations and published data have shown fenbendazole’s efficacy as a radical treatment for human malignancies.
Treatment with fenbendazole may slow the progression of large B-cell lymphoma, renal cell carcinoma, bladder cancer, or metastatic sickness in patients.
Fenbendazole’s risk of side effects is minimal at best.
It may be acquired at any local drugstore in the United States without the need for a prescription.
Production expenses are shockingly inexpensive.
In contrast, in our previous essay we discussed how fenbendazole works and how its anti-tumor effects are similar to those of the taxane groups employed in chemotherapy. Fenbendazole’s remarkable profile and one-of-a-kind effects on the body’s physiological systems serve to explain why it has a lower degree of toxicity compared to other chemotherapeutic drugs.
Parasites, viruses, and other microbes have been linked to the development of most human malignancies.
The actual etiology of most cases of cancer is unknown, but it is thought that hereditary components combine with a compromised immune system to develop cancer, creating an environment that encourages uncontrolled proliferation of tumor cells.
It is common practice to investigate the use of anti-worm, anti-parasite, and anti-lactate medications when normal tumor therapies are combined with protracted chemotherapy or cancer treatment.
Fenbendazole is widely used as a therapy for parasitic infections in humans.
Fenbendazole, unlike mebendazole, was originally used to treat parasitic diseases and worms in animals, including roundworms, tapeworms, hookworms, and whipworms. In the beginning, mebendazole helped those who had parasitic illnesses or worms.
The drug fenbendazole, marketed under the brand names Safe-Guard and Panacur, dominated the pharmaceutical market virtually immediately after its introduction. Studies on humans and animals have revealed that it greatly decreases cancer risk. This amazing cure was brought to mind when a man with small cell lung cancer had this “worm-eating” therapy and thereafter claimed being cancer-free.
Later, he created a website and a Facebook group for individuals with chronic illnesses to interact with others who could relate to their experiences. His research suggests that fenbendazole might be an effective therapy for a wide range of disorders, including but not limited to colon and prostate cancers, melanoma, stage four pancreatic cancer, and non-small lung cancer.
Scientific proof for the actions and applications of numerous benzimidazole compounds in the treatment of human cancers has been provided by these recent studies. It is well known that mebendazole and fenbendazole both contain the active components that make them effective against cancer.
Fenbendazole has been demonstrated to be more successful than mebendazole in the treatment of cancer. Fenbendazole seems to be more effective than mebendazole and other medications against Cryptococcus neoformans (a fungus that exists in all environments and causes Cryptococcus meningitis in humans). Fenbendazole is a drug that has been repeatedly shown to have compounds that inhibit the growth of cancer cells in the lab, making it a promising anti-cancer agent. The results of this study contribute to the growing body of evidence that fenbendazole may alter many molecular pathways to slow the growth of cancer cells, ultimately leading to their demise.
All in all, our results support our hypothesis that fenbendazole is an effective microtubule-destabilizing medication with anti-neoplastic properties that may speed the death of cancer cells by modifying many cellular pathways.
The researchers say that fenbendazole kills human cancer cells by reducing glucose absorption in cancer cells by lowering GLUT transporter regulation and by depolymerizing microtubules, which alters microtubule dynamics. The drug’s effects are thought to originate from two distinct pathways. Fenbendazole is the medicine of choice for preventing GLUT 4 activity (glucose transporter isoform 4). Insulin increases glucose absorption by bringing GLUT4 from intracellular vesicles to the plasma membrane. Fenbendazole significantly reduces insulin-induced glucose absorption by blocking trans-microtubule migration.
Although fenbendazole for humans interacts with the same site on tubulin as colchicine does, its structural modifications exclude its use as a chemotherapeutic medication in place of other vinca alkaloids. Fenbendazole is one of numerous benzimidazole drugs that may boost the efficacy of radiation treatment, surgery, berberine, sodium dichloroacetate (DCA), and other chemotherapeutic methods in the battle against cancer.
A recently published research in a scientific publication suggests that the drug fenbendazole, along with others like it, may reactivate the p53 gene inside the genome. The p53 gene, which functions as a tumor suppressor, possesses anti-cancer properties. Named the Genome Guardian in popular culture. It has the potential to be employed as a therapeutic therapy for a broad range of cancers due to its ability to suppress tumor development.
How dangerous may it be for humans to ingest fenbendazole?
When treating helminth infections, pure fenbendazole is often given to patients. Anecdotal evidence suggests that when fenbendazole is given orally to people, very few side effects occur (in single dosages of 2000 mg and 500 mg, respectively, over 10 days). Researchers from the European Medicines Agency got to this conclusion over the course of their examination.
But there is less evidence that long-term drug abuse is damaging to health. The medication’s ability to efficiently cure infections within the prescribed time frame is the main reason for this.
However, Fenben Lab fenbendazole has been used effectively to treat cancer and keep the illness from returning for a very long period. As there have been almost no reported side effects, it would seem that the therapies are perfectly safe.